New & Noteworthy

Submit New & Noteworthy

October 2010

Automated IV Compounding

McKesson US Pharma & Specialty

McKesson announces the availability of Health Robotics’ CytoCare, an automated system for compounding hazardous IVs used in chemotherapy, monoclonal antibody therapy, and genetic therapy. The system helps hospital pharmacies increase accuracy, reduce manual errors, and improve efficiencies when preparing hazardous IVs. Automating the process of compounding IVs decreases injury and exposure risks by protecting pharmacy staff from product selection and measurement errors, as well as from needle stick injuries.

Click here to view product detail on Findit.

Current Issue

Enter our Sweepstakes now for your chance to win the following prizes:

Just answer the following quick question for your chance to win:

To continue, you must either login or register: